WHO and MPP welcomed NIHメs offer of COVID-19 health technologies to C-TAP
On Mar. 3, 2022, the WHO and the Medicines Patent Pool (MPP) jointly welcomed the announcement that the…
On Mar. 3, 2022, the WHO and the Medicines Patent Pool (MPP) jointly welcomed the announcement that the…
On Mar. 3, 2022, a study carried out in southwestern Ontario identified a highly mutated variant of SARS-CoV-2…
On Mar. 2, 2022, Roche announced an initial donation of essential medicines to Ukraine. Roche is working diligently…
On Mar. 1, 2022, the CDC reported that Two doses of Pfizer-BioNTech vaccine protect against COVID-19ヨassociated emergency department…
On Feb. 25, 2022, researchers announced that wildlife reservoirs of SARS-CoV-2 can lead to viral adaptation and spillback…
On Feb. 24, 2022, researchers from the University of Oxford have used data from UK Biobank participants to…
On Feb. 23, 2022, Sanofi and GSK today announce that they intend to submit data from both their…
On Feb. 23, 2022, Agilent Technologies announced that researchers at the Indian Institute of Technology Bombay in India…
On Jan. 24, 2022, researchers from the University of Oxfordメs Big Data Institute announced a major step towards…
On Feb. 18, 2022, the WHO announced the first six countries that will receive the technology needed to…
On Feb. 17, 2022, after studying blood samples from 244 patients hospitalized for COVID-19, a group of researchers,…
On Feb. 16, 2022, Moderna announced that the Therapeutic Goods Administration in Australia had granted provisional registration for…
On Feb. 16, 2022, BioNTech announced it had introduced its approach to establishing scalable vaccine production by developing…
On Feb. 16, 2022, the McKelvey School of Engineering at Washington University in St. Louis, announced that it…
On Feb. 11, 2022, Pfizer and BioNTech announced plans to extend their rolling submission to the U.S. Food…
On Feb. 11, 2022, Roche announced that Actemraᆴ/RoActemraᆴ (tocilizumab) intravenous (IV) had been granted World Health Organization (WHO)…
On Feb. 11, 2022, the WHO announced the addition of tocilizumab, a monoclonal antibody, to its list of…
On Feb. 10, 2022, Vir Biotech announced that preclinical data suggested that sotrovimab, an investigational monoclonal antibody authorized…
On Feb. 10, 2022, Scripps Research announced that the COVID-causing virus SARS-CoV-2 harbors a vulnerable site at the…
On Feb. 8, 2022, Howard Hughes Medical Institute (HHMI) announced The program, named Codetta, can read the genome…
On Feb. 4, 2022, the NIH announced a study that showed pregnant women with COVID-19 appeared to be…
On Feb. 7, 2022, scientists working with the Queen Mary University of London and the London Genome Centre…
On Feb. 4, 2022, the NIH reported that Staphylococcus epidermidis produces enzymes, known as sphingomyelinase, that help the…
On Feb. 4, 2022, a new ᆪ1.6m collaborative project was launched to rapidly identify new treatments for COVID-19….
On Feb. 4, 2022, pet hamsters probably carried the Delta variant of SARS-CoV-2 into Hong Kong and sparked…
On Feb. 3, 2022, Novavax announced that the Medicines and Healthcare products Regulatory Agency had granted conditional marketing…
On Feb. 2, 2022, the U.S. Food and Drug Administration announced it had approved the first generic of…
On Feb. 2, 2022, President Biden announced a reignition of the Cancer Moonshot, that highlighted new goals: to…
On Feb. 1, 2022, Pfizer and BioNTech announced that following a request from the U.S. Food and Drug…
On Jan. 31, 2022, OraSure Technologies announced that its InteliSwabᆴ COVID-19 rapid tests had been authorized by the…